Your browser doesn't support javascript.
loading
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes.
Grosso, Dolores; Carabasi, Matthew; Filicko-O'Hara, Joanne; Wagner, John L; O'Hara, William; Sun, Michael; Colombe, Beth; Shi, W; Werner-Wasik, Maria; Rudolph, Shannon; Alpdogan, Onder; Binder, Adam; Kasner, Margaret; Klumpp, Thomas; Martinez-Outschoorn, Ubaldo; Palmisiano, Neil; Wilde, Lindsay; Porcu, Pierluigi; Gergis, Usama; Flomenberg, Neal.
  • Grosso D; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: lorigrosso@gmail.com.
  • Carabasi M; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Filicko-O'Hara J; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Wagner JL; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • O'Hara W; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Sun M; Blood and Marrow Transplant Cell Processing Lab, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Colombe B; Department of Pathology, Tissue Typing, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Shi W; Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Werner-Wasik M; Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Rudolph S; Clinical Research Office, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Alpdogan O; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Binder A; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Kasner M; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Klumpp T; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Martinez-Outschoorn U; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Palmisiano N; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Wilde L; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Porcu P; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Gergis U; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Flomenberg N; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Biol Blood Marrow Transplant ; 26(10): 1861-1867, 2020 10.
Article en En | MEDLINE | ID: mdl-32629157
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article